With over 900,000 US patients undergoing bone-related surgeries each year, a New York based start-up called EpiBone wants to simplify how we construct new bone. Their technology, while still being tested, is a revolutionary procedure that utilizes a patients' own stem cells to engineer a personalized bone graft, giving surgeons simplified procedures and patients highly accurate bone formation and regeneration without the complication of synthetic implants.